Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: The reduced transverse relaxation rate

NMR in Biomedicine

Volumn 24, Issue 7, 2011, Pages 771-777

  Kim, Daniel ^a   Jensen, Jens H ^a   Wu, Ed X ^b   Feng, Li ^a   Au, Wing Yan ^b   Cheung, Jerry S ^c   Ha, Shau Yin ^b   Sheth, Sujit S ^d   Brittenham, Gary M ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d College of Physicians and Surgeons ^*  (United States)

Author keywords

Cardiomyopathy; Heart; Iron chelation; MRI

Indexed keywords

CHELATION; HEART; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT;

CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCES; IRON CHELATION; LOW MOLECULAR WEIGHT; OXIDATIVE DAMAGE; RAPID ASSESSMENT; RAPID MONITORING; TRANSVERSE RELAXATION RATE;

IRON;

DEFERASIROX; FERRITIN; HEMOSIDERIN; IRON CHELATING AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CYTOSOL; EXPLANT; FEMALE; HEART MUSCLE; HUMAN; IRON CHELATION; IRON OVERLOAD; MALE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PHANTOM; PRIORITY JOURNAL; THALASSEMIA MAJOR;

EID: 80051583462     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1639     Document Type: Article

References (37)

1. Borgna-Pignatti C, Cappellini M, De Stefano P, Del Vecchio G, Forni G, Gamberini M, Ghilardi R, Origa R, Piga A, Romeo M, Zhao H, Cnaan A. Survival and complications in thalassemia. Ann. NY Acad. Sci. 2005; 1054: 40-47.
2. Wood J. History and current impact of cardiac magnetic resonance imaging on the management of iron overload. Circulation, 2009; 120(20): 1937-1939.
3. * magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation, 2009; 120(20): 1961-1968.
4. * cardiovascular magnetic resonance. Br. J. Haematol. 2004; 127(3): 348-355.
5. Pennell DJ, Porter JB, Cappellini MD, El-Beshlawy A, Chan LL, Aydinok Y, Elalfy MS, Sutcharitchan P, Li CK, Ibrahim H, Viprakasit V, Kattamis A, Smith G, Habr D, Domokos G, Roubert B, Taher A. Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. Blood, 2010; 115(12): 2364-2371.
6. Miyazaki E, Kato J, Kobune M, Okumura K, Sasaki K, Shintani N, Arosio P, Niitsu Y. Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut, 2002; 50(3): 413-419.
7. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int. J. Hematol. 2008; 88(1): 7-15.
8. Breuer W, Shvartsman M, Cabantchik ZI. Intracellular labile iron. Int. J. Biochem. Cell Biol. 2008; 40(3): 350-354.
9. Porter JB. Concepts and goals in the management of transfusional iron overload. Am. J. Hematol 2007; 82 (12 Suppl): 1136-1139.
10. Kuryshev Y, Brittenham G, Fujioka H, Kannan P, Shieh C, Cohen S, Brown A. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease. Circulation, 1999; 100(6): 675-683.
11. Obejero-Paz C, Yang T, Dong W, Levy M, Brittenham G, Kuryshev Y, Brown A. Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy. J. Lab. Clin. Med. 2003; 141(2): 121-130.
12. Wood JC, Enriquez C, Ghugre N, Otto-Duessel M, Aguilar M, Nelson MD, Moats R, Coates TD. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann. NY Acad. Sci. 2005; 1054: 386-395.
13. Hershko C, Cappellini M, Galanello R, Piga A, Tognoni G, Masera G. Purging iron from the heart. Br. J. Haematol. 2004; 125(5): 545-551.
14. De Domenico I, Vaughn M, Li L, Bagley D, Musci G, Ward D, Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006; 25(22): 5396-5404.
15. Jensen JH, Chandra R. Theory of nonexponential NMR signal decay in liver with iron overload or superparamagnetic iron oxide particles. Magn. Reson. Med. 2002; 47(6): 1131-1138.
16. Jensen J, Tang H, Tosti C, Swaminathan S, Nunez A, Hultman K, Szulc K, Wu E, Kim D, Sheth S, Brown T, Brittenham G. Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn. Reson. Med. 2010; 63: 1201-1209.
17. Tosti C, Wojczyk B, Sheth S, Kim D, Tang H, Jensen J, Brittenham G, Brown T. MR iron quantification of soluble (ferritin-like) and insoluble (hemosiderin-like) iron: a biochemical validation in human liver explants. In: Proceedings of the 18th Annual Meeting ISMRM, Stockholm, Sweden, 2010; Program No. 4982.
18. Kim D, Jensen JH, Wu E, Sheth S, Brittenham GM. Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver. Magn. Reson. Med 2009; 62(2): 300-306.
19. * cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J. Magn. Reson. Imaging, 2003; 18(1): 33-39.
20. Griswold M, Jakob P, Heidemann R, Nittka M, Jellus V, Wang J, Kiefer B, Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002; 47(6): 1202-1210.
21. Pell GS, Briellmann RS, Waites AB, Abbott DF, Lewis DP, Jackson GD. Optimized clinical T2 relaxometry with a standard CPMG sequence. J. Magn. Reson. Imaging, 2006; 23(2): 248-252.
22. McGibney G, Smith MR. An unbiased signal-to-noise ratio measure for magnetic resonance images. Med. Phys. 1993; 20(4): 1077-1078.
23. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood, 2004; 103(5): 1934-1936.
24. Stone H, Orchard M, Chang E, Martucci S. A fast direct Fourier-based algorithm for subpixel registration of images. IEEE Trans. Geosci. Remote Sensing, 2001; 39(10): 2235-2243.
25. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Earlbaum Associates: Hillsdale, NJ, 1988.
26. *) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 2001; 22(23): 2171-2179.
27. * segmental artefacts. NMR Biomed. 2007; 20(6): 578-590.
28. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood, 2005; 106(4): 1460-1465.
29. Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn. Reson. Med. 2003; 50(5): 1031-1042.
30. Senegas J, Liu W, Dahnke H, Song H, Jordan E, Frank J. Fast T2 relaxometry with an accelerated multi-echo spin-echo sequence. NMR Biomed. 2010; 23: 958-967.
31. Lustig M, Donoho D, Pauly JM. Sparse MRI: the application of compressed sensing for rapid MR imaging. Magn. Reson. Med. 2007; 58(6): 1182-1195.
32. Feng L, Otazo R, Jensen JH, Sodickson D, Kim D. Accelerated breath-hold multi-echo FSE pulse sequence using compressed sensing and parallel imaging for T2 measurement in the heart. Proceedings of the 18th Annual Meeting ISMRM, Stockholm, Sweden, 2010; Program No. 351.
33. Shi H, Bencze KZ, Stemmler TL, Philpott CC. A cytosolic iron chaperone that delivers iron to ferritin. Science, 2008; 320: 1207-1210.
34. De Domenico I, Ward D, Kaplan J. Specific iron chelators determine the route of ferritin degradation. Blood, 2009; 114(20): 4546-4551.
35. Lam WW, Au WY, Chu WC, Tam S, Ha SY, Pennell DJ. One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J. Magn. Reson. Imaging, 2008; 28(1): 29-33.
36. Noetzli L, Carson S, Nord A, Coates T, Wood J. Longitudinal analysis of heart and liver iron in thalassemia major. Blood, 2008; 112(7): 2973-2978.
37. Sheth S, Tang H, Jensen JH, Altmann K, Prakash A, Printz BF, Hordof AJ, Tosti CL, Azabagic A, Swaminathan S, Brown TR, Olivieri NF, Brittenham GM. Methods for noninvasive measurement of tissue iron in Cooley's anemia. Ann. NY Acad. Sci. 2005; 1054: 358-372.